Logo

Nanosphere Licenses Protein Detection Technology from Northwestern University

Oct 08, 2003

NEW YORK, Oct. 8 (GenomeWeb News) – Chicago-based Nanosphere today announced that it has licensed a detection technology for protein analytes from Northwestern University.
The technology was developed by Nanosphere co-founder and Northwestern University professor Chad Merkin and described in the Sept. 26 issue of Science .
Financial details of the licensing deal were not disclosed.
The method is based on magnetic microparticle probes with antibodies that specifically bind a target of interest and nanoparticle probes that are encoded with DNA that is unique to the protein target of interest and antibodies that can sandwich the target captured by the probes, the article says.
The technology was first applied to detecting prostate specific antigen.
The company said it plans to combine the technology with its detection systems for DNA.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.